Genetic Testing Markets Accelerate: Comprehensive Global Analysis and Forecasts Revealed for 2023-2027 - The Emergence of Precision Medicine in Health Management

Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides 2023 to 2027" report has been added to's offering.

A groundbreaking research publication focused on global genetic testing markets has been added to our spectrum of industry analyses. This comprehensive dossier offers a deep dive into the expanding frontiers of genetic testing technologies, product developments, applications, and users—an area experiencing an unprecedented growth trajectory.

As the nexus between genomics and healthcare continues to bolster the development of tailored therapeutic interventions, this report evaluates the exciting opportunities and potential pitfalls that lie ahead. With a spotlight on the integration of predictive diagnostics, pharmacogenomic testing, and direct-to-consumer offerings, the analysis dissects the nuances of technological advancements that redefine our approach to health and disease.

The Emergence of Precision Medicine in Health Management

The inclusion of genetic nuances in medicinal efficacy underscores a new era in drug prescription and administration. Genetic-based therapies that cater to specific genetic profiles are not just a possibility, but a present reality shaping the landscape of treatment protocols across the globe.

Granular Market Insights Across Regions and Sectors

This report’s robust breakdown encompasses detailed analysis for key countries and regions, spotlighting growth dynamics in various segments of genetic testing. The insights provided reflect the nuances of regional market expansions and the diverse portfolio of tests that encompass both existing applications and emerging frontiers.

Forward-Looking Sector Analysis

This multi-faceted report is designed to arm stakeholders with pertinent data for strategic decision-making:

  • In-depth understanding of market growth expectations over a five-year forecast period
  • Expertise-driven insights into the burgeoning field of genetic testing, with applications spanning from preventative health diagnostics to advanced therapeutic interventions
  • Identification of growth opportunities, alongside a prudent examination of industry challenges

With this latest addition to our research cache, stakeholders can navigate the complex landscape of genetic testing markets with authoritative knowledge and a forward-looking perspective.

The dynamic data encompassed within this publication provides a comprehensive compass for informed investment decisions and thoughtful valuation practices, making it an indispensable resource for industry professionals looking to steer their organizations through the flourishing terrain of genetic testing.

Market Trends

Factors Driving Growth

  • Genetic Discoveries Creating New Diagnostic Markets
  • The Aging Effect
  • Pharmacogenomics Drives Further Growth
  • Oncology and Liquid Biopsy Enter New Era
  • Fertility Practice Growth drives market
  • Direct to Consumer begins to break out

Factors Limiting Growth

  • Increased Competition Lowers Price
  • Lower Costs
  • Testing usage analysis curtailing growth
  • Wellness has a downside

Instrumentation, Automation and Diagnostic Trends

  • Traditional Automation and Centralization
  • The New Automation, Decentralization and Point of Care
  • Instruments Key to Market Share
  • Bioinformatics Plays a Role
  • PCR Takes Command
  • Next Generation Sequencing Fuels a Revolution
  • NGS Impact on Pricing
  • Whole Genome Sequencing, A Brave New World
  • Companion Diagnostics Blurs Diagnosis and Treatment
  • Shifting Role of Diagnostics

Companies Mentioned

  • 10x Genomics, Inc.
  • 23andME Inc.
  • Abbott Laboratories
  • Adaptive Biotechnologies
  • Admera Health, LLC
  • Agilent/Dako
  • Akonni Biosystems
  • Amoy Diagnostics Co., Ltd.
  • LLC
  • Anchor Dx
  • Arc Bio
  • Arrayit Corporation
  • ARUP Laboratories
  • Aus Diagnostics
  • BaseClear
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • Bioarray Genetics
  • Biocept, Inc.
  • Biodesix Inc.
  • BioFluidica
  • BioGenex
  • Biolidics Ltd
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • C2i Genomics
  • CareDx
  • Caris Molecular Diagnostics
  • CellMax Life
  • Centogene
  • Cepheid (Danaher)
  • Circulogene
  • Clinical Genomics
  • Color Genomics
  • Complete Genomics, Inc. - A BGI Company
  • CosmosID
  • Dante Labs
  • Datar Cancer Genetics Limited
  • Diasorin S.p.A.
  • Element Biosciences
  • Element Biosciences
  • Epic Sciences
  • Epigenomics AG.
  • Eurofins Scientific
  • Excellerate Bioscience
  • Fabric Genomics
  • Freenome
  • Fujirebio
  • Fulgent Genetics
  • Gene by Gene, Ltd.
  • Genedrive
  • GeneFirst Ltd.
  • Genetron Holdings
  • Genomics England
  • Genomics Personalized Health (GPH)
  • GenomOncology
  • Genzyme Corporation
  • Grifols
  • Guardant Health
  • Guardiome
  • HeiScreen
  • Helix
  • Helix OpCo
  • Helomics
  • Hologic
  • HTG Molecular Diagnostics
  • Human Longevity, Inc.
  • iCellate
  • Illumina
  • Incell Dx
  • Inivata
  • Integrated Diagnostics
  • Invitae Corporation
  • Invivoscribe
  • Karius
  • Letsgetchecked
  • Lunglife AI Inc
  • Macrogen
  • MDNA Life SCIENCES, Inc.
  • MDx Health
  • Medgenome
  • Menarini Silicon Biosystems
  • Meridian Bioscience
  • Mesa Biotech (Thermo Fisher)
  • Mesa Laboratories, Inc.
  • Metabiomics Corp
  • miR Scientific
  • MNG Labs
  • NantHealth, Inc.
  • Natera
  • Nebula Genomics
  • NeoGenomics
  • New England Biolabs, Inc.
  • NGeneBio
  • Novogene Bioinformatics Technology Co., Ltd.
  • Omega Bioservices
  • Oncocyte
  • OncoDNA
  • OpGen
  • ORIG3N, Inc.
  • Origene Technologies
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Panagene
  • PathoQuest S.A.
  • Perkin Elmer (now Revvity)
  • Personal Genome Diagnostics
  • Personalis.
  • Precipio
  • PrecisionMed
  • Promega
  • Protagen Diagnostics
  • Qiagen
  • QuantuMDx
  • Roche Molecular Diagnostics
  • Roswell Biotechnologies
  • Seegene
  • Sema4 Holdings
  • Siemens Healthineers
  • simfo GmbH
  • Singlera Genomics Inc.
  • Singular Genomics
  • SkylineDx
  • Standard BioTools
  • Sure Genomics, Inc.
  • Sysmex
  • Sysmex Inostics
  • Tempus Labs, Inc.
  • Thermo Fisher Scientific Inc.
  • Ultima Genomics
  • Ultima Genomics
  • Variantyx
  • Vela Diagnostics
  • Volition
  • Vyant Bio
  • Zymo Research Corp

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Contact Data